Saratoga Research & Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,776
| Closed | -$212K | – | 49 |
|
|
2023
Q2 | $212K | Buy |
5,776
+12
| +0.2% | +$467 | 0.01% | 46 |
|
|
2023
Q1 | $235K | Hold |
5,764
| – | – | 0.01% | 44 |
|
|
2022
Q4 | $295K | Sell |
5,764
-16
| -0.3% | -$767 | 0.01% | 40 |
|
|
2022
Q3 | $253K | Sell |
5,780
-41
| -0.7% | -$1.99K | 0.01% | 44 |
|
|
2022
Q2 | $305K | Hold |
5,821
| – | – | 0.02% | 41 |
|
|
2022
Q1 | $301K | Sell |
5,821
-67
| -1% | -$3.48K | 0.01% | 42 |
|
|
2021
Q4 | $348K | Sell |
5,888
-126
| -2% | -$6.24K | 0.01% | 42 |
|
|
2021
Q3 | $259K | Hold |
6,014
| – | – | 0.01% | 42 |
|
|
2021
Q2 | $236K | Sell |
6,014
-157
| -3% | -$6.11K | 0.01% | 40 |
|
|
2021
Q1 | $224K | Sell |
6,171
-214
| -3% | -$7.6K | 0.01% | 41 |
|
|
2020
Q4 | $235K | Sell |
6,385
-345
| -5% | -$12.7K | 0.01% | 40 |
|
|
2020
Q3 | $234K | Sell |
6,730
-109
| -2% | -$3.82K | 0.01% | 39 |
|
|
2020
Q2 | $212K | Hold |
6,839
| – | – | 0.01% | 41 |
|
|
2020
Q1 | $212K | Hold |
6,839
| – | – | 0.01% | 41 |
|
|
2019
Q4 | $254K | Hold |
6,839
| – | – | 0.02% | 42 |
|
|
2019
Q3 | $233K | Hold |
6,839
| – | – | 0.02% | 41 |
|
|
2019
Q2 | $281K | Buy |
6,839
+120
| +2% | +$4.76K | 0.02% | 40 |
|
|
2019
Q1 | $271K | Sell |
6,719
-311
| -4% | -$12.5K | 0.02% | 42 |
|
|
2018
Q4 | $291K | Hold |
7,030
| – | – | 0.02% | 37 |
|
|
2018
Q3 | $294K | Sell |
7,030
-316
| -4% | -$12.2K | 0.02% | 42 |
|
|
2018
Q2 | $253K | Hold |
7,346
| – | – | 0.02% | 43 |
|
|
2018
Q1 | $247K | Hold |
7,346
| – | – | 0.02% | 41 |
|
|
2017
Q4 | $252K | Hold |
7,346
| – | – | 0.02% | 44 |
|
|
2017
Q3 | $249K | Hold |
7,346
| – | – | 0.02% | 42 |
|
|
2017
Q2 | $234K | Hold |
7,346
| – | – | 0.02% | 47 |
|
|
2017
Q1 | $238K | Hold |
7,346
| – | – | 0.02% | 45 |
|
|
2016
Q4 | $226K | Hold |
7,346
| – | – | 0.02% | 45 |
|
|
2016
Q3 | $236K | Sell |
7,346
-369
| -5% | -$12.3K | 0.02% | 43 |
|
|
2016
Q2 | $258K | Hold |
7,715
| – | – | 0.02% | 44 |
|
|
2016
Q1 | $217K | Hold |
7,715
| – | – | 0.02% | 47 |
|
|
2015
Q4 | $236K | Sell |
7,715
-1,529
| -17% | -$48.1K | 0.02% | 48 |
|
|
2015
Q3 | $275K | Hold |
9,244
| – | – | 0.03% | 45 |
|
|
2015
Q2 | $294K | Hold |
9,244
| – | – | 0.03% | 45 |
|
|
2015
Q1 | $305K | Hold |
9,244
| – | – | 0.03% | 45 |
|
|
2014
Q4 | $273K | Hold |
9,244
| – | – | 0.03% | 49 |
|
|
2014
Q3 | $259K | Sell |
9,244
-5,270
| -36% | -$148K | 0.03% | 49 |
|
|
2014
Q2 | $409K | Buy |
14,514
+5,270
| +57% | +$150K | 0.04% | 40 |
|
|
2014
Q1 | $282K | Sell |
9,244
-737
| -7% | -$22K | 0.03% | 49 |
|
|
2013
Q4 | $290K | Hold |
9,981
| – | – | 0.03% | 48 |
|
|
2013
Q3 | $272K | Hold |
9,981
| – | – | 0.03% | 48 |
|
|
2013
Q2 | $265K | Buy |
+9,981
| New | +$276K | 0.03% | 52 |
|
Other funds holding PFE
Saratoga Research & Investment Management's PFE Position: Q3 2023 in Review
Saratoga Research & Investment Management sold out of Pfizer (PFE) in Q3 2023, closing a stake of 5,776 shares — an estimated $212K sold.
Saratoga Research & Investment Management first reported a position in PFE in Q2 2013 and held it in 41 quarters. The position peaked at $409K in Q2 2014. 2,927 funds tracked by Wall St. Rank hold PFE as of Q3 2023.
- Saratoga Research & Investment Management reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
- Saratoga Research & Investment Management sold 5,776 Pfizer shares in Q3 2023, an estimated $212K.
- Saratoga Research & Investment Management first reported a position in Pfizer in Q2 2013 and held it in 41 quarters.
- Saratoga Research & Investment Management's Pfizer position peaked at $409K in Q2 2014.
- 2,927 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.
Based on Saratoga Research & Investment Management's 13F filing for Q3 2023, filed 9 Nov 2023.